Literature DB >> 23215154

Regioselective synthesis of 2-amino-substituted 1,3,4-oxadiazole and 1,3,4-thiadiazole derivatives via reagent-based cyclization of thiosemicarbazide intermediate.

Seung-Ju Yang1, Seok-Hyeong Lee, Hyun-Jung Kwak, Young-Dae Gong.   

Abstract

A regioselective, reagent-based method for the cyclization reaction of 2-amino-1,3,4-oxadiazole and 2-amino-1,3,4-thiadiazole core skeletons is described. The thiosemicarbazide intermediate 3 was reacted with EDC·HCl in DMSO or p-TsCl, triethylamine in N-methyl-2-pyrrolidone to give the corresponding 2-amino-1,3,4-oxadiazoles 4 and 2-amino-1,3,4-thiadiazoles 5 through regioselcective cyclization processes. The regioselectivity was affected by both R(1) and R(2) in p-TsCl mediated cyclization. It is shown in select sets of thiosemicarbazide 3 with R(1)(benzyl) and R(2)(phenyl). 2-Amino-1,3,4-oxadiazole 4 was also shown in the reaction of p-TsCl mediated cyclization. The resulting 2-amino-1,3,4-oxadiazole and 2-amino-1,3,4-thiadiazole core skeleton are functionalized with various electrophiles such as alkyl halide, acid halides, and sulfornyl chloride in high yields.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23215154     DOI: 10.1021/jo302324r

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  8 in total

1.  Design and Synthesis of a Novel 4-aryl-N-(2-alkoxythieno [2,3-b]pyrazine-3-yl)-4-arylpiperazine-1-carboxamide DGG200064 Showed Therapeutic Effect on Colon Cancer through G2/M Arrest.

Authors:  Eun-Sil Lee; Nayeon Kim; Joon Hee Kang; Aizhan Abdildinova; Seon-Hyeong Lee; Myung Hwi Lee; Nam Sook Kang; Tae-Sung Koo; Soo-Youl Kim; Young-Dae Gong
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-20

Review 2.  Comparative Study of the Synthetic Approaches and Biological Activities of the Bioisosteres of 1,3,4-Oxadiazoles and 1,3,4-Thiadiazoles over the Past Decade.

Authors:  Rana M El-Masry; Hanan H Kadry; Azza T Taher; Sahar M Abou-Seri
Journal:  Molecules       Date:  2022-04-22       Impact factor: 4.927

3.  Synthesis and antimicrobial evaluation of novel 4-amino-6-(1,3,4-oxadiazolo/1,3,4-thiadiazolo)-pyrimidine derivatives.

Authors:  Poornima Shetty; B M Praveen; M Raghavendra; K Manjunath; Srinivas Cheruku
Journal:  Mol Divers       Date:  2015-10-26       Impact factor: 2.943

4.  A convenient four-component one-pot synthesis of 2-amino-1,3,4-thiadiazoles in water.

Authors:  Peng Liu; Ao-Ze Su; Yuan-Qiang Wang; Ze-Mei Ge; Tie-Ming Cheng; Run-Tao Li
Journal:  Mol Divers       Date:  2014-06-29       Impact factor: 2.943

5.  Synthesis and evaluation of 6-heteroarylamino-2,4,5-trimethylpyridin-3-ols as inhibitors of TNF-α-induced cell adhesion and inflammatory bowel disease.

Authors:  Sang Won Park; Suhrid Banskota; Pallavi Gurung; You Jin Jin; Han-Eol Kang; Chhabi Lal Chaudhary; Sang Yeul Lee; Byeong-Seon Jeong; Jung-Ae Kim; Tae-Gyu Nam
Journal:  Medchemcomm       Date:  2018-06-08       Impact factor: 3.597

6.  Synthesis and cytotoxic activity evaluation of some new 1, 3, 4-oxadiazole, 1, 3, 4-thiadiazole and 1, 2, 4- triazole derivatives attached to phthalimide.

Authors:  Farshid Hassanzadeh; Elham Jafari; Faezeh Shojaei; Hojjat Sadeghi-Aliabadi
Journal:  Res Pharm Sci       Date:  2021-10-15

7.  Synthesis of 2-Imino-1,3,4-oxadiazolines from Acylhydrazides and Isothiocyanates via Aerobic Oxidation and a DMAP-Mediated Annulation Sequence.

Authors:  Jae Hyeok Lim; Sang Eun Baek; Bapurao Sudam Lad; Jinho Kim
Journal:  ACS Omega       Date:  2022-08-01

8.  Discovery of Substituted Di(pyridin-2-yl)-1,2,4-thiadiazol-5-amines as Novel Macrofilaricidal Compounds for the Treatment of Human Filarial Infections.

Authors:  Natalie Hawryluk; Dale Robinson; Yixing Shen; Graham Kyne; Matthew Bedore; Sanjay Menon; Stacie Canan; Thomas von Geldern; Simon Townson; Suzanne Gokool; Alexandra Ehrens; Marianne Koschel; Nathaly Lhermitte-Vallarino; Coralie Martin; Achim Hoerauf; Geraldine Hernandez; Deepak Dalvie; Sabine Specht; Marc Peter Hübner; Ivan Scandale
Journal:  J Med Chem       Date:  2022-08-16       Impact factor: 8.039

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.